Benzinga | Jan 10, 2022 09:02AM EST

Barclays Maintains Underweight on Illumina, Lowers Price Target to $350

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:ILMN) with a Underweight and lowers the price target from $365 to $350.